Snowball logo
logo
6000

China Resources Double-Crane Pharmaceutical Co Ltd

600062 SHG
¥18.41-¥0.16  (0.86%)

Frequently asked questions

What sector does China Resources Double-Crane Pharmaceutical Co Ltd (600062) operate in?

China Resources Double-Crane Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is China Resources Double-Crane Pharmaceutical Co Ltd (600062) current stock price?

As of the latest data, China Resources Double-Crane Pharmaceutical Co Ltd stock price is CN¥18.41, with a previous close of CN¥18.57. China Resources Double-Crane Pharmaceutical Co Ltd lost -CN¥0.16 in the last trading session, representing a -0.86% loss.

What is China Resources Double-Crane Pharmaceutical Co Ltd (600062) current market capitalization?

China Resources Double-Crane Pharmaceutical Co Ltd market cap is approximately 19.12 billion.

What is China Resources Double-Crane Pharmaceutical Co Ltd (600062) Earnings Per Share (EPS)?

The trailing EPS is CN¥1.59.

What is China Resources Double-Crane Pharmaceutical Co Ltd (600062) Price-to-Earnings (P/E) ratio?

China Resources Double-Crane Pharmaceutical Co Ltd current P/E ratio is 11.58.

What is China Resources Double-Crane Pharmaceutical Co Ltd (600062) EBITDA?

China Resources Double-Crane Pharmaceutical Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 542.05 million.

Does China Resources Double-Crane Pharmaceutical Co Ltd (600062) pay dividends?

No. China Resources Double-Crane Pharmaceutical Co Ltd does not pay a dividend.

What is China Resources Double-Crane Pharmaceutical Co Ltd (600062) beta (volatility) score?

China Resources Double-Crane Pharmaceutical Co Ltd has a beta of 0.056, indicating lower volatility than the overall market.